Browsing byAuthorShaw, JM
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) |
| 2024-04-01 | Changes in psychosocial distress and the number and types of problems reported by patients with cancer when routine screening is integrated within cancer services | Faris, MM; Shepherd, HL; Butow, PN; Kelly, P; He, S; Grimison, P; Kelly, B; Shaw, JM; Beale, P; Clayton, J; Cuddy, J; Davies, F; Dhillon, H; Geerligs, L; Girgis, A; Hack, T; Harris, M; Kirsten, L; Lindsay, T; Lovell, M; Luckett, T; Masya, L; Murphy, M; Newby, J; Piro, D; Rankin, N; Shaw, T; Viney, R; Yim, J |
| 2004-01-01 | Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease | Martiniello-Wilks, R; Dane, A; Voeks, DJ; Jeyakumar, G; Mortensen, E; Shaw, JM; Wang, XY; Both, GW; Russell, PJ |
| 2004-11-01 | Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus | Wang, XY; Martiniello-Wilks, R; Shaw, JM; Ho, T; Coulston, N; Cooke-Yarborough, C; Molloy, PL; Cameron, F; Moghaddam, M; Lockett, TJ; Webster, LK; Smith, IK; Both, GW; Russel, PJ |
| 2004-12-01 | Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer | Martiniello-Wilks, R; Wang, XY; Voeks, DJ; Dane, A; Shaw, JM; Mortensen, E; Both, GW; Russell, PJ |
| 2020-07-29 | The value of real-world testing: a qualitative feasibility study to explore staff and organisational barriers and strategies to support implementation of a clinical pathway for the management of anxiety and depression in adult cancer patients. | Geerligs, L; Shepherd, HL; Rankin, NM; Masya, L; Shaw, JM; Price, MA; Dhillon, H; Dolan, C; Prest, G; ADAPT Program Group; Butow, P |
